BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19155278)

  • 1. Analysis of the eukaryotic topoisomerase II DNA gate: a single-molecule FRET and structural perspective.
    Collins TR; Hammes GG; Hsieh TS
    Nucleic Acids Res; 2009 Feb; 37(3):712-20. PubMed ID: 19155278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-molecule measurements of the opening and closing of the DNA gate by eukaryotic topoisomerase II.
    Smiley RD; Collins TR; Hammes GG; Hsieh TS
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4840-5. PubMed ID: 17360343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring the topoisomerase II DNA gate conformational change with fluorescence resonance energy transfer.
    Collins TR; Hsieh TS
    Methods Mol Biol; 2009; 582():59-70. PubMed ID: 19763942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-molecule Förster resonance energy transfer (FRET) analysis discloses the dynamics of the DNA-topoisomerase II (Top2) interaction in the presence of TOP2-targeting agents.
    Huang WC; Lee CY; Hsieh TS
    J Biol Chem; 2017 Jul; 292(30):12589-12598. PubMed ID: 28630044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
    Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
    Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases.
    Schmidt BH; Burgin AB; Deweese JE; Osheroff N; Berger JM
    Nature; 2010 Jun; 465(7298):641-4. PubMed ID: 20485342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for gate-DNA recognition and bending by type IIA topoisomerases.
    Dong KC; Berger JM
    Nature; 2007 Dec; 450(7173):1201-5. PubMed ID: 18097402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling ATP hydrolysis to DNA strand passage in type IIA DNA topoisomerases.
    Maxwell A; Costenaro L; Mitelheiser S; Bates AD
    Biochem Soc Trans; 2005 Dec; 33(Pt 6):1460-4. PubMed ID: 16246146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA supercoiling and relaxation by ATP-dependent DNA topoisomerases.
    Fisher LM; Austin CA; Hopewell R; Margerrison EE; Oram M; Patel S; Plummer K; Sng JH; Sreedharan S
    Philos Trans R Soc Lond B Biol Sci; 1992 Apr; 336(1276):83-91. PubMed ID: 1351300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of the poisoned topoisomerase II for DNA religation: coordinated motion of the cleavage core revealed with the microsecond atomistic simulation.
    Huang NL; Lin JH
    Nucleic Acids Res; 2015 Aug; 43(14):6772-86. PubMed ID: 26150421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenesis of E477 or K505 in the B' domain of human topoisomerase II beta increases the requirement for magnesium ions during strand passage.
    West KL; Meczes EL; Thorn R; Turnbull RM; Marshall R; Austin CA
    Biochemistry; 2000 Feb; 39(6):1223-33. PubMed ID: 10684600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands.
    Fass D; Bogden CE; Berger JM
    Nat Struct Biol; 1999 Apr; 6(4):322-6. PubMed ID: 10201398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of an intact type II DNA topoisomerase: insights into DNA transfer mechanisms.
    Graille M; Cladière L; Durand D; Lecointe F; Gadelle D; Quevillon-Cheruel S; Vachette P; Forterre P; van Tilbeurgh H
    Structure; 2008 Mar; 16(3):360-70. PubMed ID: 18334211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate.
    Zechiedrich EL; Christiansen K; Andersen AH; Westergaard O; Osheroff N
    Biochemistry; 1989 Jul; 28(15):6229-36. PubMed ID: 2551367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II.
    Robinson MJ; Osheroff N
    Biochemistry; 1991 Feb; 30(7):1807-13. PubMed ID: 1847075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular choreography: Unveiling the dynamic landscape of type IIA DNA topoisomerases before T-segment passage through all-atom simulations.
    Herlah B; Pavlin M; Perdih A
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):131991. PubMed ID: 38714283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The path of the DNA along the dimer interface of topoisomerase II.
    Roca J
    J Biol Chem; 2004 Jun; 279(24):25783-8. PubMed ID: 15047688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of strand passage catalyzed by topoisomerase II.
    Xie P
    Eur Biophys J; 2010 Jul; 39(8):1251-9. PubMed ID: 20127325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in understanding structure-function relationships in the type II topoisomerase mechanism.
    Schoeffler AJ; Berger JM
    Biochem Soc Trans; 2005 Dec; 33(Pt 6):1465-70. PubMed ID: 16246147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What's on the Other Side of the Gate: A Structural Perspective on DNA Gate Opening of Type IA and IIA DNA Topoisomerases.
    Vidmar V; Vayssières M; Lamour V
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.